Mouwasat Medical Services (4002) Stock Overview
Engages in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 4002 from our risk checks.
4002 Community Fair Values
Create NarrativeSee what 45 others think this stock is worth. Follow their fair value or set your own to get alerts.
Mouwasat Medical Services Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س72.50 |
| 52 Week High | ر.س103.80 |
| 52 Week Low | ر.س65.60 |
| Beta | 0.37 |
| 1 Month Change | -2.95% |
| 3 Month Change | -3.46% |
| 1 Year Change | -29.47% |
| 3 Year Change | -26.77% |
| 5 Year Change | 15.08% |
| Change since IPO | 908.70% |
Recent News & Updates
Earnings Beat: Mouwasat Medical Services Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 07
Mouwasat Medical Services Company's (TADAWUL:4002) P/E Is On The Mark
Jun 02Mouwasat Medical Services Company (TADAWUL:4002) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 12Recent updates
Earnings Beat: Mouwasat Medical Services Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 07Mouwasat Medical Services Company's (TADAWUL:4002) P/E Is On The Mark
Jun 02Mouwasat Medical Services Company (TADAWUL:4002) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 12Slowing Rates Of Return At Mouwasat Medical Services (TADAWUL:4002) Leave Little Room For Excitement
Apr 02Mouwasat Medical Services' (TADAWUL:4002) Soft Earnings Are Actually Better Than They Appear
Mar 12Investors Appear Satisfied With Mouwasat Medical Services Company's (TADAWUL:4002) Prospects
Feb 14The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Dec 12Do Mouwasat Medical Services' (TADAWUL:4002) Earnings Warrant Your Attention?
Sep 30The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Sep 12Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear
Aug 06Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
Jul 01Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear
Apr 23Here's Why We Think Mouwasat Medical Services (TADAWUL:4002) Might Deserve Your Attention Today
Mar 18Slowing Rates Of Return At Mouwasat Medical Services (TADAWUL:4002) Leave Little Room For Excitement
Jan 23Here's Why Mouwasat Medical Services (TADAWUL:4002) Has Caught The Eye Of Investors
Dec 17Mouwasat Medical Services (TADAWUL:4002) Has Some Way To Go To Become A Multi-Bagger
Oct 05Should You Be Adding Mouwasat Medical Services (TADAWUL:4002) To Your Watchlist Today?
Sep 17The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Jul 03Is Now The Time To Put Mouwasat Medical Services (TADAWUL:4002) On Your Watchlist?
Jun 12Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down
Feb 24Mouwasat Medical Services Company's (TADAWUL:4002) Intrinsic Value Is Potentially 25% Below Its Share Price
Jan 18Return Trends At Mouwasat Medical Services (TADAWUL:4002) Aren't Appealing
Nov 24Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down
Aug 24A Look At The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Jul 01Time To Worry? Analysts Just Downgraded Their Mouwasat Medical Services Company (TADAWUL:4002) Outlook
May 23Mouwasat Medical Services (TADAWUL:4002) Will Pay A Larger Dividend Than Last Year At ر.س2.75
Apr 29Mouwasat Medical Services (TADAWUL:4002) Is Increasing Its Dividend To ر.س2.75
Apr 15Investors Will Want Mouwasat Medical Services' (TADAWUL:4002) Growth In ROCE To Persist
Mar 17Calculating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Mar 02If You Like EPS Growth Then Check Out Mouwasat Medical Services (TADAWUL:4002) Before It's Too Late
Feb 15The Return Trends At Mouwasat Medical Services (TADAWUL:4002) Look Promising
Dec 06Do Mouwasat Medical Services's (TADAWUL:4002) Earnings Warrant Your Attention?
Nov 16Mouwasat Medical Services (TADAWUL:4002) Is Achieving High Returns On Its Capital
Aug 29Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
Aug 12Is Mouwasat Medical Services Company (TADAWUL:4002) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 29Mouwasat Medical Services' (TADAWUL:4002) Returns On Capital Are Heading Higher
May 26Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
May 11Is It Worth Buying Mouwasat Medical Services Company (TADAWUL:4002) For Its 1.4% Dividend Yield?
Apr 13Estimating The Intrinsic Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Mar 16Is Mouwasat Medical Services Company's (TADAWUL:4002) Latest Stock Performance Being Led By Its Strong Fundamentals?
Mar 02Is Mouwasat Medical Services (TADAWUL:4002) A Future Multi-bagger?
Feb 13Here's Why I Think Mouwasat Medical Services (TADAWUL:4002) Is An Interesting Stock
Feb 01
What Kind Of Shareholders Hold The Majority In Mouwasat Medical Services Company's (TADAWUL:4002) Shares?
Jan 17What Makes Mouwasat Medical Services Company (TADAWUL:4002) A Great Dividend Stock?
Jan 04Mouwasat Medical Services (TADAWUL:4002) Has Gifted Shareholders With A Fantastic 137% Total Return On Their Investment
Dec 21Shareholder Returns
| 4002 | SA Healthcare | SA Market | |
|---|---|---|---|
| 7D | -0.5% | 3.3% | 1.4% |
| 1Y | -29.5% | -20.4% | -11.6% |
Return vs Industry: 4002 underperformed the SA Healthcare industry which returned -20.4% over the past year.
Return vs Market: 4002 underperformed the SA Market which returned -9.7% over the past year.
Price Volatility
| 4002 volatility | |
|---|---|
| 4002 Average Weekly Movement | 2.9% |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in SA Market | 7.6% |
| 10% least volatile stocks in SA Market | 2.5% |
Stable Share Price: 4002 has not had significant price volatility in the past 3 months compared to the SA market.
Volatility Over Time: 4002's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | n/a | Nasser Sultan Al-Subaie | www.mouwasat.com |
Mouwasat Medical Services Company, together with its subsidiaries, engages in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. The company operates a network of hospitals that provides medical services; and specialized centers, including eye, long term, rehabilitation, and cardiology centers, as well as stroke unit, nuclear medicine, fertility, diabetes and diabetic foot, skin care, and badana clinic. It also provides various services comprising inpatient pharmacy services, TPN and IV medication preparation units, chemotherapy medication preparation, anti-coagulant clinic, and clinical pharmacy services.
Mouwasat Medical Services Company Fundamentals Summary
| 4002 fundamental statistics | |
|---|---|
| Market cap | ر.س14.50b |
| Earnings (TTM) | ر.س705.50m |
| Revenue (TTM) | ر.س3.03b |
Is 4002 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4002 income statement (TTM) | |
|---|---|
| Revenue | ر.س3.03b |
| Cost of Revenue | ر.س1.71b |
| Gross Profit | ر.س1.32b |
| Other Expenses | ر.س611.38m |
| Earnings | ر.س705.50m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.53 |
| Gross Margin | 43.50% |
| Net Profit Margin | 23.31% |
| Debt/Equity Ratio | 25.1% |
How did 4002 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/25 18:05 |
| End of Day Share Price | 2025/09/25 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Mouwasat Medical Services Company is covered by 25 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ibrahim Elaiwat | Aljazira Capital Company |
| Jassim Al-Jubran | Aljazira Capital Company |
| Rim Ben Salah Gharbi | AlphaMena |